Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1171

1.

Placental pathology in live births conceived with in vitro fertilization after fresh and frozen embryo transfer.

Sacha CR, Harris AL, James K, Basnet K, Freret TS, Yeh J, Kaimal A, Souter I, Roberts DJ.

Am J Obstet Gynecol. 2019 Oct 4. pii: S0002-9378(19)31213-X. doi: 10.1016/j.ajog.2019.09.047. [Epub ahead of print]

PMID:
31589863
2.

Development of therapeutic anti-JAGGED1 antibodies for cancer therapy.

Masiero M, Li D, Whiteman P, Bentley C, Greig J, Hassanali T, Watts S, Stribbling S, Yates J, Bealing E, Li JL, Chillakuri C, Sheppard D, Serres S, Sarmiento-Soto M, Larkin J, Sibson NR, Handford PA, Harris AL, Banham AH.

Mol Cancer Ther. 2019 Aug 8. pii: molcanther.1176.2018. doi: 10.1158/1535-7163.MCT-18-1176. [Epub ahead of print]

PMID:
31395687
3.

Unrequited love: The role of prior commitment, motivation to remain friends, and friendship maintenance.

Clark EM, Votaw KLB, Harris AL, Hasan M, Fernandez P.

J Soc Psychol. 2019 Jul 30:1-17. doi: 10.1080/00224545.2019.1648234. [Epub ahead of print]

PMID:
31362604
4.

Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis.

Giatromanolaki A, Koukourakis IM, Balaska K, Mitrakas AG, Harris AL, Koukourakis MI.

Med Oncol. 2019 Jul 24;36(9):76. doi: 10.1007/s12032-019-1299-4.

PMID:
31342270
5.

Landscape of transcriptomic interactions between breast cancer and its microenvironment.

Fox NS, Haider S, Harris AL, Boutros PC.

Nat Commun. 2019 Jul 15;10(1):3116. doi: 10.1038/s41467-019-10929-z.

6.
7.

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.

Morotti M, Bridges E, Valli A, Choudhry H, Sheldon H, Wigfield S, Gray N, Zois CE, Grimm F, Jones D, Teoh EJ, Cheng WC, Lord S, Anastasiou D, Haider S, McIntyre A, Goberdhan DCI, Buffa F, Harris AL.

Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12452-12461. doi: 10.1073/pnas.1818521116. Epub 2019 May 31.

8.

FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma.

Giatromanolaki A, Banham AH, Harris AL, Koukourakis MI.

Exp Lung Res. 2019 Apr - May;45(3-4):76-83. doi: 10.1080/01902148.2019.1617371. Epub 2019 May 28.

PMID:
31134811
9.

Impact of obesity on male and female reproductive outcomes.

Glenn T, Harris AL, Lindheim SR.

Curr Opin Obstet Gynecol. 2019 Aug;31(4):201-206. doi: 10.1097/GCO.0000000000000549.

PMID:
31022079
10.

Guidelines for using sigQC for systematic evaluation of gene signatures.

Dhawan A, Barberis A, Cheng WC, Domingo E, West C, Maughan T, Scott JG, Harris AL, Buffa FM.

Nat Protoc. 2019 May;14(5):1377-1400. doi: 10.1038/s41596-019-0136-8. Epub 2019 Apr 10.

PMID:
30971781
11.

Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism.

Valli A, Morotti M, Zois CE, Albers PK, Soga T, Feldinger K, Fischer R, Frejno M, McIntyre A, Bridges E, Haider S, Buffa FM, Baban D, Rodriguez M, Yanes O, Whittington HJ, Lake HA, Zervou S, Lygate CA, Kessler BM, Harris AL.

Mol Cancer Res. 2019 Jul;17(7):1531-1544. doi: 10.1158/1541-7786.MCR-18-0315. Epub 2019 Mar 18.

PMID:
30885992
12.

Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors.

Dhawan A, Scott JG, Harris AL, Buffa FM.

Nat Commun. 2018 Dec 7;9(1):5228. doi: 10.1038/s41467-018-07657-1.

13.

The connexin26 human mutation N14K disrupts cytosolic intersubunit interactions and promotes channel opening.

Valdez Capuccino JM, Chatterjee P, García IE, Botello-Smith WM, Zhang H, Harris AL, Luo Y, Contreras JE.

J Gen Physiol. 2019 Mar 4;151(3):328-341. doi: 10.1085/jgp.201812219. Epub 2018 Dec 7.

14.

3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers.

Jones DT, Valli A, Haider S, Zhang Q, Smethurst EA, Schug ZT, Peck B, Aboagye EO, Critchlow SE, Schulze A, Gottlieb E, Wakelam MJO, Harris AL.

Mol Cancer Ther. 2019 Feb;18(2):376-388. doi: 10.1158/1535-7163.MCT-17-0857. Epub 2018 Nov 26.

15.

Sexual Misconduct Policies at Institutes of Higher Education: An Integrative Review.

McNair KT, Fantasia HC, Harris AL.

J Forensic Nurs. 2018 Oct/Dec;14(4):238-247. doi: 10.1097/JFN.0000000000000216. Review.

PMID:
30433911
16.

Semen parameters on the day of oocyte retrieval predict low fertilization during conventional insemination IVF cycles.

Harris AL, Vanegas JC, Hariton E, Bortoletto P, Palmor M, Humphries LA, Tanrikut C, Chavarro JE, Styer AK.

J Assist Reprod Genet. 2019 Feb;36(2):291-298. doi: 10.1007/s10815-018-1336-9. Epub 2018 Nov 10.

PMID:
30415469
17.

Electrical coupling and its channels.

Harris AL.

J Gen Physiol. 2018 Dec 3;150(12):1606-1639. doi: 10.1085/jgp.201812203. Epub 2018 Nov 2. Review.

18.

Endogenous miRNA sponges mediate the generation of oscillatory dynamics for a non-coding RNA network.

Dhawan A, Harris AL, Buffa FM, Scott JG.

J Theor Biol. 2019 Nov 21;481:54-60. doi: 10.1016/j.jtbi.2018.10.055. Epub 2018 Oct 30.

PMID:
30385313
19.

Father 2 Son: The Impact of African American Father-Son Sexual Communication on African American Adolescent Sons' Sexual Behaviors.

Harris AL, Fantasia HC, Castle CE.

Am J Mens Health. 2019 Jan-Feb;13(1):1557988318804725. doi: 10.1177/1557988318804725. Epub 2018 Oct 12.

PMID:
30311826
20.

Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer.

Lord SR, Cheng WC, Liu D, Gaude E, Haider S, Metcalf T, Patel N, Teoh EJ, Gleeson F, Bradley K, Wigfield S, Zois C, McGowan DR, Ah-See ML, Thompson AM, Sharma A, Bidaut L, Pollak M, Roy PG, Karpe F, James T, English R, Adams RF, Campo L, Ayers L, Snell C, Roxanis I, Frezza C, Fenwick JD, Buffa FM, Harris AL.

Cell Metab. 2018 Nov 6;28(5):679-688.e4. doi: 10.1016/j.cmet.2018.08.021. Epub 2018 Sep 20.

21.

Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo.

Lee SH, McIntyre D, Honess D, Hulikova A, Pacheco-Torres J, Cerdán S, Swietach P, Harris AL, Griffiths JR.

Br J Cancer. 2018 Aug;119(5):622-630. doi: 10.1038/s41416-018-0216-5. Epub 2018 Sep 12.

22.

Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.

Sly JR, Harris AL.

Nurs Womens Health. 2018 Oct;22(5):417-422. doi: 10.1016/j.nwh.2018.07.004. Epub 2018 Aug 24.

PMID:
30145235
23.

A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis.

Tsoukalas C, Psimadas D, Kastis GA, Koutoulidis V, Harris AL, Paravatou-Petsotas M, Karageorgou M, Furenlid LR, Moulopoulos LA, Stamopoulos D, Bouziotis P.

Front Chem. 2018 Jun 20;6:224. doi: 10.3389/fchem.2018.00224. eCollection 2018.

24.

Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases.

Kannan P, Kretzschmar WW, Winter H, Warren D, Bates R, Allen PD, Syed N, Irving B, Papiez BW, Kaeppler J, Markelc B, Kinchesh P, Gilchrist S, Smart S, Schnabel JA, Maughan T, Harris AL, Muschel RJ, Partridge M, Sharma RA, Kersemans V.

Clin Cancer Res. 2018 Oct 1;24(19):4694-4704. doi: 10.1158/1078-0432.CCR-18-0033. Epub 2018 Jun 29.

25.

The glycerol backbone of phospholipids derives from noncarbohydrate precursors in starved lung cancer cells.

Leithner K, Triebl A, Trötzmüller M, Hinteregger B, Leko P, Wieser BI, Grasmann G, Bertsch AL, Züllig T, Stacher E, Valli A, Prassl R, Olschewski A, Harris AL, Köfeler HC, Olschewski H, Hrzenjak A.

Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6225-6230. doi: 10.1073/pnas.1719871115. Epub 2018 May 29.

26.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

27.

Whole Exome Sequencing and Molecular Modeling of a Missense Variant in TNFAIP3 That Segregates with Disease in a Family with Chronic Urticaria and Angioedema.

Harris AL, Blackburn PR, Richter JE Jr, Gass JM, Caulfield TR, Mohammad AN, Atwal PS.

Case Rep Genet. 2018 Feb 22;2018:6968395. doi: 10.1155/2018/6968395. eCollection 2018.

28.

Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF V600E -mutant melanoma.

Harris AL, Lee SE, Dawson LK, Marlow LA, Edenfield BH, Durham WF, Flotte TJ, Thompson M, Small DL, Synnott AJ, Markovic SN, Copland JA.

Oncotarget. 2017 Dec 23;9(13):10905-10919. doi: 10.18632/oncotarget.23649. eCollection 2018 Feb 16.

29.

Non-angiogenic tumours and their influence on cancer biology.

Donnem T, Reynolds AR, Kuczynski EA, Gatter K, Vermeulen PB, Kerbel RS, Harris AL, Pezzella F.

Nat Rev Cancer. 2018 May;18(5):323-336. doi: 10.1038/nrc.2018.14. Epub 2018 Mar 9. Review.

PMID:
29520090
30.

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424.

Woodcock VK, Clive S, Wilson RH, Coyle VM, Stratford MRL, Folkes LK, Eastell R, Barton C, Jones P, Kazmi-Stokes S, Turner H, Halford S, Harris AL, Middleton MR.

Br J Cancer. 2018 Mar 20;118(6):770-776. doi: 10.1038/bjc.2017.484. Epub 2018 Feb 13.

31.

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.

Earwaker P, Anderson C, Willenbrock F, Harris AL, Protheroe AS, Macaulay VM.

PLoS One. 2018 Feb 1;13(2):e0191890. doi: 10.1371/journal.pone.0191890. eCollection 2018.

32.

SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy.

Koukourakis MI, Giatromanolaki A, Fylaktakidou K, Sivridis E, Zois CE, Kalamida D, Mitrakas A, Pouliliou S, Karagounis IV, Simopoulos K, Ferguson DJP, Harris AL.

Invest New Drugs. 2018 Oct;36(5):773-781. doi: 10.1007/s10637-018-0566-0. Epub 2018 Jan 31.

PMID:
29387992
33.

Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer.

Yang J, Harris AL, Davidoff AM.

Int J Mol Sci. 2018 Jan 13;19(1). pii: E240. doi: 10.3390/ijms19010240. Review.

34.

Amifostine Protects Mouse Liver Against Radiation-induced Autophagy Blockage.

Koukourakis MI, Giatromanolaki A, Fylaktakidou K, Kouroupi M, Sivridis E, Zois CE, Kalamida D, Mitrakas A, Pouliliou S, Karagounis IV, Simopoulos K, Ferguson DJP, Harris AL.

Anticancer Res. 2018 Jan;38(1):227-238.

PMID:
29277777
35.

miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense.

Pajic M, Froio D, Daly S, Doculara L, Millar E, Graham PH, Drury A, Steinmann A, de Bock CE, Boulghourjian A, Zaratzian A, Carroll S, Toohey J, O'Toole SA, Harris AL, Buffa FM, Gee HE, Hollway GE, Molloy TJ.

Cancer Res. 2018 Jan 15;78(2):501-515. doi: 10.1158/0008-5472.CAN-16-3105. Epub 2017 Nov 27.

36.

Single-cell heterogeneity in ductal carcinoma in situ of breast.

Gerdes MJ, Gökmen-Polar Y, Sui Y, Pang AS, LaPlante N, Harris AL, Tan PH, Ginty F, Badve SS.

Mod Pathol. 2018 Mar;31(3):406-417. doi: 10.1038/modpathol.2017.143. Epub 2017 Nov 17.

37.

Advances in Hypoxia-Inducible Factor Biology.

Choudhry H, Harris AL.

Cell Metab. 2018 Feb 6;27(2):281-298. doi: 10.1016/j.cmet.2017.10.005. Epub 2017 Nov 9. Review.

38.

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.

Milani M, Venturini S, Bonardi S, Allevi G, Strina C, Cappelletti MR, Corona SP, Aguggini S, Bottini A, Berruti A, Jubb A, Campo L, Harris AL, Gatter K, Fox SB, Generali D, Roviello G.

Oncotarget. 2017 Aug 14;8(45):78870-78881. doi: 10.18632/oncotarget.20239. eCollection 2017 Oct 3.

39.

Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients.

Morotti M, Dass PH, Harris AL, Lord S.

Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):137-153. doi: 10.1007/s13318-017-0442-x. Review.

PMID:
29019020
40.

PrEP awareness and decision-making for Latino MSM in San Antonio, Texas.

García M, Harris AL.

PLoS One. 2017 Sep 27;12(9):e0184014. doi: 10.1371/journal.pone.0184014. eCollection 2017.

41.

The evaluation of extraction techniques for Tetranychus urticae (Acari: Tetranychidae) from apple (Malus domestica) and cherry (Prunus avium) leaves.

Harris AL, Ullah R, Fountain MT.

Exp Appl Acarol. 2017 Aug;72(4):367-377. doi: 10.1007/s10493-017-0154-6. Epub 2017 Aug 22.

PMID:
28831615
42.

Intramolecular signaling in a cardiac connexin: Role of cytoplasmic domain dimerization.

Trease AJ, Capuccino JMV, Contreras J, Harris AL, Sorgen PL.

J Mol Cell Cardiol. 2017 Oct;111:69-80. doi: 10.1016/j.yjmcc.2017.07.010. Epub 2017 Jul 25.

43.

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.

Abu-Jamous B, Buffa FM, Harris AL, Nandi AK.

Mol Cancer. 2017 Jun 15;16(1):105. doi: 10.1186/s12943-017-0673-0.

44.

Assessing Marijuana Use During Pregnancy.

Harris AL, Okorie CS.

Nurs Womens Health. 2017 Jun - Jul;21(3):207-216. doi: 10.1016/j.nwh.2017.04.001.

PMID:
28599742
45.

Genomic instability induced in distant progeny of bystander cells depends on the connexins expressed in the irradiated cells.

de Toledo SM, Buonanno M, Harris AL, Azzam EI.

Int J Radiat Biol. 2017 Oct;93(10):1182-1194. doi: 10.1080/09553002.2017.1334980. Epub 2017 Jun 15.

PMID:
28565963
46.

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab.

Patel N, Able S, Allen D, Fokas E, Cornelissen B, Gleeson FV, Harris AL, Vallis KA.

EJNMMI Res. 2017 Dec;7(1):49. doi: 10.1186/s13550-017-0297-9. Epub 2017 May 30.

47.

Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation.

Dos Santos SN, Sheldon H, Pereira JX, Paluch C, Bridges EM, El-Cheikh MC, Harris AL, Bernardes ES.

Oncotarget. 2017 Jul 25;8(30):49484-49501. doi: 10.18632/oncotarget.17718.

48.

Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.

Zhao Y, Lai Y, Ge H, Guo Y, Feng X, Song J, Wang Q, Fan L, Peng Y, Cao M, Harris AL, Wang X, Tao L.

Cell Death Dis. 2017 May 11;8(5):e2773. doi: 10.1038/cddis.2017.183.

49.

Endothelial cAMP deactivates ischemia-reperfusion-induced microvascular hyperpermeability via Rap1-mediated mechanisms.

Korayem AH, Mujica PE, Aramoto H, Durán RG, Nepali PR, Kim DD, Harris AL, Sánchez FA, Durán WN.

Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H179-H189. doi: 10.1152/ajpheart.00002.2017. Epub 2017 May 5.

50.

Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.

Oon CE, Bridges E, Sheldon H, Sainson RCA, Jubb A, Turley H, Leek R, Buffa F, Harris AL, Li JL.

Oncotarget. 2017 Jun 20;8(25):40115-40131. doi: 10.18632/oncotarget.16969.

Supplemental Content

Loading ...
Support Center